Dr. Sayed Hamid Mousavi is currently employed at Kateb University as the Assistant Professor for Clinical Biochemistry Department of Medical Sciences, Kateb University since 2011. Since 2011, I have been head of health committee of the Afghanistan Hemophilia Patients Association (AHPA). From 2015 to 2017, I worked in Professor Zeinli’s genetic laboratory in Tehran, Iran, and I was trained in all the necessary courses for the diagnosis of genetic diseases, and more than 200 types of genetic diseases were diagnosed with all molecular devices such as I learned PCR, sequences, etc. Since 2017, as the director of the Afghanistan National Charity Organization for Specific Diseases (ANCOSD), I have conducted many scientific projects, research on specific diseases such as hemophilia, thalassemia, hepatitis, etc.Since 2017, I have been the managing director of the first health weekly called LABKHAND, which focused on specific diseases.And since 2020, I have been working as the director of research at Kateb University. Dr. Mousavi has a PhD in field of Clinical Biochemistry specialized from Tarbiat Modares University in Tehran (2018). He has a master’s degree in Clinical Biochemistry (2011). He got his bachelor’s degree in Laboratory sciences from Zabol University in (2007). Dr. Mousavi has published books name “Biochemistry 1, Biochemistry 2, Molecular Biology, Practical Biochemistry and Nutrition” in Kabul, Afghanistan, , And he has several other articles and research work experience such as follows:
Published Articles:
6.Investigating the influence of LCT rs3754689 polymorphism on inhibitor development in Iranian and Afghan patients with severe hemophilia A. Sobhan Bahrami Zadegan, Sayed H. Mousavi, Narges Damavandi, Mohammad H. Samiee Aref and Sirous Zeinali. Blood Coagulation and Fibrinolysis 2019, 30:00–00.
11.Factor XIII Deficiency in Western Afghanistan due to a Novel F13A Gene Mutation.SH Mousavi, S Zeinali, SA Mesbah‐Namin,M Shams,A Dorgalaleh. International journal of laboratory hematology, 28 May 2019. https://doi.org/10.1111/ijlh.13050.
14.Frequencies of intron 1 and 22 inversions of factor VIII gene: A first report in Afghan patients with severe haemophilia A. SH Mousavi, SA Mesbah‐Namin, N Rezaie, S Zeinali. Haemophilia .2018;24 (3), e157-e160.
